Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-03-10 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion · Restricted Stock Unit −4,687 4,688
2015-03-10 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion · Restricted Stock Unit −2,344 4,688
2015-03-10 Kelly James Patrick SVP, CFO, Sec & Treasurer Exercise or conversion · Restricted Stock Unit −5,000 15,000
2015-03-10 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion +12,500 34,485
2015-03-10 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion +5,000 39,485
2015-03-10 Baroldi Paolo SVP & Chief Medical Officer Sale −8,940 $10.54 $94K 30,545
2015-03-10 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion · Restricted Stock Unit −12,500 25,000
2015-03-10 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion · Restricted Stock Unit −5,000 15,000
2015-03-09 DUGAN RICHARD W Director Exercise or conversion +10,574 $4.73 $50K 10,574
2015-03-09 DUGAN RICHARD W Director Sale −4,804 $10.69 $51K 5,770
2015-03-09 DUGAN RICHARD W Director Exercise or conversion · Nonqualified Stock Option (Right to Buy) −10,574 0
2015-02-05 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion +48,154 $0.03 $2K 552,018
2015-02-05 Polymeropoulos Mihael Hristos President and CEO Shares withheld for taxes −24,947 $11.28 $281K 527,071
2015-02-05 Polymeropoulos Mihael Hristos President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −48,154 0
2014-12-23 Flynn James E 10% owner Purchase +11,100 $14.23 $158K 1,285,881
2014-12-23 Flynn James E 10% owner Purchase +13,900 $14.23 $198K 1,598,601
2014-12-23 Flynn James E 10% owner Purchase +13,320 $14.48 $193K 1,299,201
2014-12-23 Flynn James E 10% owner Purchase +16,680 $14.48 $242K 1,615,281
2014-12-23 Flynn James E 10% owner Purchase +11,100 $14.50 $161K 1,310,301
2014-12-23 Flynn James E 10% owner Purchase +13,900 $14.50 $202K 1,629,181

Page 30 of 36 · 717 trades